Spots Global Cancer Trial Database for Study of SHR6390 in Renal Insufficiency and Healthy Subjects
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of SHR6390 in Renal Insufficiency and Healthy Subjects
Official Title: Study of SHR6390 in Renal Insufficiency and Healthy Subjects
Study ID: NCT05515289
Conditions
Interventions
Study Description
Brief Summary: The study is a single-center, open, single-dose, self-controlled clinical trial. It is planned to enroll 24-30 subjects. Subjects will take the SHR6390 on Day1.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Zhongda Hospital Southesat University, Nanjing, Jiangsu, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
